Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 32 (RPL12P32) is a processed pseudogene in the human genome related to the functional RPL12 gene, which encodes a component of the large (60S) subunit of the ribosome. As a pseudogene, RPL12P32 does not code for a functional protein and is not known to have a biological function, role in disease, or relevance as a therapeutic target. It may have arisen through gene duplication or retrotransposition events and is catalogued alongside several other RPL12-derived pseudogenes in the human genome. RPL12P32 is listed as a pseudogene, not a protein-coding or functional gene, and does not produce a protein product. Pseudogenes are generally considered non-functional genomic elements, often remnants of once-functional genes that have lost coding potential due to mutations or truncations; thus, they are not therapeutic targets. This entry is not a valid drug target; it is a non-coding sequence with no associated protein, function, or pathology. The actual, functional gene is RPL12 (Ribosomal protein L12), which encodes a ribosomal structural protein of the 60S subunit, but RPL12P32 itself is not involved in any known cellular function, diseases, or therapeutics. There are several similar pseudogenes for ribosomal proteins catalogued in the human genome with analogous nomenclature (RPL12P1, RPL12P2, etc.).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 32 (RPL12P32).